These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17107249)

  • 1. Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.
    Papp LA
    J Clin Psychiatry; 2006 Oct; 67(10):1573-6. PubMed ID: 17107249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam for treatment-refractory posttraumatic stress disorder.
    Kinrys G; Wygant LE; Pardo TB; Melo M
    J Clin Psychiatry; 2006 Feb; 67(2):211-4. PubMed ID: 16566615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study of levetiracetam for the treatment of social anxiety disorder.
    Simon NM; Worthington JJ; Doyle AC; Hoge EA; Kinrys G; Fischmann D; Link N; Pollack MH
    J Clin Psychiatry; 2004 Sep; 65(9):1219-22. PubMed ID: 15367048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam as adjunctive therapy for refractory anxiety disorders.
    Kinrys G; Worthington JJ; Wygant L; Nery F; Reese H; Pollack MH
    J Clin Psychiatry; 2007 Jul; 68(7):1010-3. PubMed ID: 17685735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
    J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
    Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
    J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
    Post RM; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich GS; Kupka R; Nolen WA; Luckenbaugh DA; Walden J; Grunze H
    J Clin Psychiatry; 2005 Mar; 66(3):370-4. PubMed ID: 15766304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective pilot study of levetiracetam for body dysmorphic disorder.
    Phillips KA; Menard W
    CNS Spectr; 2009 May; 14(5):252-60. PubMed ID: 19407724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
    Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU
    Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label trial of risperidone augmentation for refractory anxiety disorders.
    Simon NM; Hoge EA; Fischmann D; Worthington JJ; Christian KM; Kinrys G; Pollack MH
    J Clin Psychiatry; 2006 Mar; 67(3):381-5. PubMed ID: 16649823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertraline in the treatment of panic disorder: a double-blind multicenter trial.
    Pohl RB; Wolkow RM; Clary CM
    Am J Psychiatry; 1998 Sep; 155(9):1189-95. PubMed ID: 9734541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
    Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
    Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.
    Prosser JM; Yard S; Steele A; Cohen LJ; Galynker II
    BMC Psychiatry; 2009 May; 9():25. PubMed ID: 19470174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.